Trial Profile
Costimulation Inhibition in Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 22 May 2012 Actual end date Feb 2012 added as reported by ClinicalTrials.gov.
- 22 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.